Use our chat feature to speak with one of our expert consultants who can help you identify if medical cannabis can help you.
3 min read
Sam North
CBD is a cannabinoid sourced from cannabis and hemp plants. CBD products that contain less than 1 mg of THC (the psychoactive cannabinoid) per container are legal for over-the-counter sale.
Prescribed cannabis-based medicines can contain the same levels of CBD but are legally allowed to contain higher levels of THC.
CBD is one of the many cannabinoids produced by the Cannabis sativa L. genus.
Along with THC (the psychoactive compound responsible for that "high" feeling), there are over 100 other cannabinoids found in different strains of cannabis and hemp plants. CBD and THC are the two 'major' cannabinoids, meaning they are found in far higher concentrations than the others.
Both medical cannabis and CBD products can be sourced from cannabis strains, but CBD products (here in the UK) are mostly made from extracts of hemp plants that produce less than 0.2% THC.
THC content is what sets CBD products and medical cannabis apart. Over-the-counter CBD products are required to have less than 1 mg of THC per container, while prescription cannabis-based medicines can contain higher levels of THC.
It's not a matter of one being better than the other, but rather what your individual health goals are.
CBD products offer certain therapeutic benefits, as do medical cannabis products containing THC. There are also a variety of prescribable cannabis-based medications that offer patients a balanced concentration of both CBD and THC.
That comes down to your reasons for taking therapeutic cannabis options. But you don't have to choose one over the other, medical cannabis is now legal in the UK.
CBD products have you covered if you're looking for a natural supplement to promote overall wellness. CBD has also been shown to:
Medical cannabis products can contain the same (or more) CBD, but offer the added therapeutic benefits related to THC:
The above lists are just a small subsection of the documented therapeutic benefits associated with CBD and THC. For a more in-depth write-up, check out our education section.
The best option is to speak with a specialist who is not only registered to prescribe medical cannabis in the UK but also has experience doing so for your specific condition.
Here at Releaf, we have a team of cannabis expert clinicians who offer consultations to assess if medical cannabis is right for you. We also have a free eligibility checker that takes less than 30 seconds to complete, giving you a clear idea if you meet the initial criteria for medical cannabis.
It is important to seek medical advice before starting any new treatments. The patient advisors at Releaf are available to provide expert advice and support. Alternatively, click here to book a consultation with one of our specialist doctors.
Get comprehensive care, convenience, and confidence with an all-in-one treatment plan.
Am I eligible?Sam North, a seasoned writer with over five years' experience and expertise in medicinal cannabis, brings clarity to complex concepts, focusing on education and informed use.
Our articles are written by experts and reviewed by medical professionals or compliance specialists. Adhering to stringent sourcing guidelines, we reference peer-reviewed studies and scholarly research. View our editorial policy.
Need more help?
In today's write-up, we will explain all the factors that can and do affect the price of medical cannabis cultivars. Here at Releaf, we want to ensure that our patients are well-informed about their medication options, including the pricing factors.
Sam North
In the last two decades, global plastic production has doubled, with 400 million tonnes of plastic waste now produced every year. As one of the only UK clinics to provide medical cannabis flower in eco-friendly packaging, Releaf is committed to finding more sustainable solutions this Plastic Free July and is taking steps towards a plastic-free future.
Sarah Sinclair
Medical cannabis was legalised in the UK in 2018 for patients with health conditions known to respond to cannabis-based treatments, if conventional or licensed medications have failed to meet their needs. Because one of these health conditions is Multiple Sclerosis, Releaf are joining MS-UK for a free Webinar on the 21st of August, to explain how these treatments can be safely incorporated into MS treatment plans.
Lucy MacKinnon
